Lifeway Foods, Inc. — Q3 2016 Form 10-Q
Reporting period: Quarter and nine months ended September 30, 2016. Lifeway manufactures probiotic and cultured dairy products, primarily kefir and farmer cheese. Financial statement amounts below are in thousands of dollars unless stated otherwise.
Financial performance
| Metric | Q3 2016 | Q3 2015 | Nine months 2016 | Nine months 2015 |
|---|---|---|---|---|
| Net sales | $29,990 | $29,599 | $93,691 | $89,042 |
| Gross profit | $7,979 | $8,936 | $26,414 | $23,317 |
| Gross margin | 26.6% | 30.2% | 28.2% | 26.2% |
| Operating income | $189 | $2,053 | $4,852 | $3,511 |
| Net income (loss) | $(64) | $893 | $2,998 | $1,645 |
| Diluted earnings (loss) per share | $(0.00) | $0.05 | $0.19 | $0.10 |
- Q3 sales rose 1.3%; management attributed growth to organic and private-label volume and new products, partly offset by increased trade spending and relatively flat cream sales.
- Q3 gross margin fell 3.6 percentage points, reflecting increased trade promotion and unfavorable product mix. Selling expense rose 59.1% to $4,306, including higher advertising, salaries, and royalty expense. Operating margin fell to 0.6% from 6.9%.
- Nine-month sales grew 5.2%. Gross margin improved 2.0 percentage points, attributed to lower input costs, particularly milk, and lower trade promotion, partly offset by unfavorable mix. Selling expense increased 24.4% to $10,733, reflecting additional advertising and royalties.
- Q3 pretax income was only $17, while income tax expense was $81; the resulting effective tax rate exceeded 100%. Management cited a change in the estimated U.S. manufacturing deduction and the small pretax-income base. For nine months, the 33.0% effective tax rate included a $265 benefit from favorable settlement of uncertain tax positions.
Cash, liquidity, and debt
- At September 30, cash and cash equivalents were $9,164, versus $5,646 at year-end 2015. Current assets were $30,356 and current liabilities $11,871.
- Nine-month operating cash flow was $4,513, compared with $4,378 a year earlier. Increased inventory and receivables absorbed cash; management also cited payment timing.
- Investing activities provided net cash of $373, compared with $1,800 used in the prior-year period. The company liquidated its investment portfolio during Q3 for general corporate purposes. Capital expenditures were $2,481, up from $1,619.
- Financing activities used $1,368, including $630 of debt repayment and $738 spent repurchasing 69,000 shares. Approximately $1,214 remained under the share-repurchase authorization at September 30.
- Total notes payable were $7,329, including $840 current maturities. The company had no borrowings on its $5 million revolving facility, which expires in July 2017. It reported compliance with debt covenants. Bank notes bear variable rates and are secured by substantially all company assets.
Business changes, outlook, and risks
- Product-category sales for the nine months increased for cream and drinkable kefir other than ProBugs ($80,135 versus $76,723) and farmer cheese ($7,579 versus $5,125); ProBugs declined to $4,962 from $5,999.
- Management provided no specific financial guidance. It said foreseeable liquidity needs are expected to be met through operating cash flow, borrowings, and cash, and that it continues to explore potential acquisitions.
- Two major customers represented approximately 22% of Q3 net sales, indicating customer concentration.
- Management disclosed ongoing lawsuits and other claims arising in the ordinary course. It considered current accruals immaterial and did not estimate a possible loss or range; an adverse outcome could nevertheless materially affect results or cash flows.
- Disclosure controls and procedures remained ineffective at quarter-end due to previously identified material weaknesses in internal control over financial reporting. Remediation was ongoing, including expanded inventory-accounting reviews and formalized disclosure certifications. Management said additional procedures supported fair presentation of the statements.
- Prior-period financial statements were revised to reclassify manufacturing overhead from general and administrative expense to cost of goods sold; prior-year executive compensation was also reclassified between selling and G&A. The filing states these classification changes did not affect operating income, pretax income, net income, EPS, balance sheets, or cash flows and were immaterial.
- Related-party arrangements include Chairman consulting fees of $787 for nine months and a product royalty of $450. A senior-executive incentive program had earned bonuses of $1,280 at September 30, including $200 of equity-based awards.
- The filing reports no material changes to previously disclosed risk factors or market-risk exposures. Advertising expense was $5,418 for nine months, versus $4,145 in 2015.
Important facts for investors to verify
- Whether Q3 margin pressure and sharply higher selling costs persist, and whether promotional spending generates sustained sales growth.
- Inventory and receivables growth, operating cash conversion, and the returns from the $2,481 in capital expenditures.
- Progress and independent validation of remediation of material weaknesses in financial reporting controls.
- Debt covenant compliance, variable-rate exposure, and refinancing or liquidity arrangements when the revolving facility expires in July 2017.
- Customer concentration, related-party consulting and royalty payments, and the cost and performance terms of executive incentives.